Renal lesions predict progression of diabetic nephropathy in type 1 diabetes

Journal of the American Society of Nephrology

Volumn 24, Issue 7, 2013, Pages 1175-1181

  Caramori, M Luiza ^a   Parks, Alicia ^a   Mauer, Michael ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C;

ADULT; ARTICLE; CLINICAL ASSESSMENT; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; GLOMERULUS BASEMENT MEMBRANE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; ONSET AGE; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

EID: 84879979804     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012070739     Document Type: Article

References (34)

1. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD; The Collaborative Study Group: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993
2. Brenner BM, CooperME, de Zeeuw D, KeaneWF, MitchWE, Parving HH, RemuzziG, Snapinn SM, Zhang Z, Shahinfar S;RENAALStudy Investigators: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl JMed 345: 861-869, 2001
3. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317: 703-713, 1998
4. USRDS: 2011 Annual Data Report, Bethesda,MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2011
5. Caramori ML, Fioretto P, Mauer M: The need for early predictors of diabetic nephropathy risk: Is albumin excretion rate sufficient? Diabetes 49: 1399-1408, 2000
6. Fioretto P, Steffes MW, Mauer M: Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 43: 1358-1364, 1994
7. Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME, Russell G, Mauer M: Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 51: 506-513, 2002
8. Caramori ML, Fioretto P, Mauer M: Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: An indicator of more advanced glomerular lesions. Diabetes 52: 1036-1040, 2003
9. Perrin NE, Torbjörnsdotter T, Jaremko GA, Berg UB: Risk markers of future microalbuminuria and hypertension based on clinical and morphological parameters in young type 1 diabetes patients. Pediatr Diabetes 11: 305-313, 2010
10. Bangstad HJ, Osterby R, Hartmann A, Berg TJ, Hanssen KF: Severity of glomerulopathy predicts long-term urinary albumin excretion rate in patients with type 1 diabetes and microalbuminuria. Diabetes Care 22: 314-319, 1999
11. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
12. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose controlwith sulphonylureas or insulin comparedwith conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998
13. Harjutsalo V, Maric C, Forsblom C, Thorn L, Waden J, Groop PH; FinnDiane Study Group: Sex-related differences in the long-term risk of microvascular complications by age at onset of type 1 diabetes. Diabetologia 54: 1992-1999, 2011
14. Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, Mauer M; International Diabetic Nephopathy Study Group: The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 54: 2164-2171, 2005
15. Najafian B, Kim Y, Crosson JT, Mauer M: Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy. J Am Soc Nephrol 14: 908-917, 2003
16. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74: 1143-1155, 1984
17. Ellis EN, SteffesMW, Goetz FC, Sutherland DE, Mauer SM: Glomerular filtration surface in type I diabetes mellitus. Kidney Int 29: 889-894, 1986
18. Drummond KN, Kramer MS, Suissa S, Levy-Marchal C, Dell'Aniello S, Sinaiko A, Mauer M; International Diabetic Nephropathy Study Group: Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes 52: 1818-1824, 2003
19. Drummond K, Mauer M; International Diabetic Nephropathy Study Group: The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 51: 1580-1587, 2002
20. Harris RD, Steffes MW, Bilous RW, Sutherland DE, Mauer SM: Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int 40: 107-114, 1991
21. Najafian B, Mauer M: Morphologic features of declining renal function in type 1 diabetes. Semin Nephrol 32: 415-422, 2012
22. Ellis EN,Warady BA,Wood EG, Hassanein R, Richardson WP, Lane PH, Howard C, Kemp SF, Aceto T, Garibaldi L, Wiegmann TB, Savin VJ: Renal structural-functional relationships in early diabetes mellitus. Pediatr Nephrol 11: 584-591, 1997
23. Rudberg S, Osterby R, Dahlquist G, Nyberg G, Persson B: Predictors of renal morphological changes in the early stage of microalbuminuria in adolescents with IDDM. Diabetes Care 20: 265-271, 1997
24. Berg UB, Torbjörnsdotter TB, Jaremko G, Thalme B: Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM. Diabetologia 41: 1047-1056, 1998
25. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165, 1989
26. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH: Is diabetic nephropathy an inherited complication? Kidney Int 41: 719-722, 1992
27. Quinn M, Angelico MC, Warram JH, Krolewski AS: Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39: 940-945, 1996
28. Chavers BM, Simonson J, Michael AF: A solid phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int 25: 576-578, 1984
29. Gaspari F, Perico N, Matalone M, Signorini O, Azzollini N, Mister M, Remuzzi G: Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease. J AmSocNephrol 9: 310-313, 1998
30. Mauer M, Drummond K: The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants. Diabetes 51: 1572-1579, 2002
31. Camargo JL, Zelmanovitz T, Paggi A, Friedman R,Gross JL: Accuracy of conversion formulae for estimation of glycohaemoglobin. Scand J Clin Lab Invest 58: 521-528, 1998
32. Jensen EB, Gundersen HJ, Osterby R: Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 115: 19-33, 1979
33. Steffes MW, Bilous RW, Sutherland DE, Mauer SM: Cell and matrix components of the glomerularmesangiumin type I diabetes. Diabetes 41: 679-684, 1992
34. Ibrahim HN, Jackson S, Connaire J, Matas A,Ney A, Najafian B,West A, Lentsch N, Ericksen J, Bodner J, Kasiske B, Mauer M: Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol 24: 320-327, 2013